{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:16:30Z","timestamp":1782274590618,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.pdpdt.2020.101907","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:15:44Z","timestamp":1593530144000},"page":"101907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Jiaqi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2020.101907_bib0005","first-page":"401","article-title":"Oral cavity and oropharyngeal squamous cell carcinoma\u2014an update","author":"Chi","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2017.06.018","article-title":"Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer","volume":"124","author":"Hosni","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jebdp.2014.12.005","article-title":"Head and neck cancer radiation therapy with and without chemotherapy may result in decreased health-related quality of life followed by a return to baseline over a 1-year period","volume":"15","author":"Psoter","year":"2015","journal-title":"J. Evid. Based Dent. Pract."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0025","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: current role of radiotherapy and chemotherapy","volume":"18","author":"Huang","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000447579","article-title":"Preoperative chemotherapy and metronomic scheduling of chemotherapy in locally advanced oral cancers","volume":"91","author":"Patil","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10147-014-0689-z","article-title":"Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma","volume":"19","author":"Omura","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0040","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1039\/C6CS00616G","article-title":"Overcoming the Achilles\u2019 heel of photodynamic therapy","volume":"45","author":"Fan","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","article-title":"Photodynamic therapy \u2013 mechanisms, photosensitizers and combinations","volume":"106","author":"Kwiatkowski","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(00)00166-2","article-title":"Photodynamic therapy: a clinical reality in the treatment of cancer","volume":"1","author":"Hopper","year":"2000","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/DSS.0000000000000633","article-title":"Daylight photodynamic therapy: what is known and what is yet to be determined","volume":"42","author":"Fitzmaurice","year":"2016","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/1011-1344(92)85108-7","article-title":"Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy","volume":"14","author":"Kennedy","year":"1992","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1039\/b703361c","article-title":"Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis","volume":"6","author":"de Bruijn","year":"2007","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oraloncology.2016.01.013","article-title":"Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors","volume":"55","author":"Ahn","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2015.12.009","article-title":"Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): a retrospective case series and cohort study","volume":"74","author":"Kessels","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0095","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2012.10878.x","article-title":"High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study","volume":"166","author":"Christensen","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.12659\/MSM.900420","article-title":"A clinical trial using attrition combined with 5-aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma","volume":"23","author":"Peng","year":"2017","journal-title":"Med. Sci. Monitor."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/clm.1996.14.289","article-title":"Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results","volume":"14","author":"Kennedy","year":"1996","journal-title":"J. Clin. Laser Med. Surg."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1039\/b109817a","article-title":"In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid","volume":"1","author":"Betz","year":"2002","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1751-1097.2011.00985.x","article-title":"An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and\/or fluorescence guided resection","volume":"87","author":"Blake","year":"2011","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1615\/JEnvironPatholToxicolOncol.v26.i2.40","article-title":"Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors","volume":"26","author":"Curnow","year":"2007","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1096\/fj.07-8888com","article-title":"Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer","volume":"22","author":"Kemmner","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s12885-016-2744-9","article-title":"Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo","volume":"16","author":"Harima","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0140","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bph.12045","article-title":"Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo","volume":"168","author":"Ford","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/0929867033457610","article-title":"Development of tridentate iron chelators: from desferrithiocin to ICL670","volume":"10","author":"Nick","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0150","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.3748\/wjg.v22.i40.8967","article-title":"Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma","volume":"22","author":"Saeki","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0155","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25421","article-title":"Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo","volume":"9","author":"Shinoda","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0160","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjc.6600910","article-title":"Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo","volume":"88","author":"Babilas","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0891-5849(02)00873-0","article-title":"Deferiprone protects against doxorubicin-induced myocyte cytotoxicity","volume":"33","author":"Barnab\u00e9","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0170","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.freeradbiomed.2003.08.005","article-title":"The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin","volume":"35","author":"Hasinoff","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0175","doi-asserted-by":"crossref","first-page":"e32972","DOI":"10.1371\/journal.pone.0032972","article-title":"Role of ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways","volume":"7","author":"Moserova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0180","first-page":"97","article-title":"Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2011.03.042","article-title":"Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage","volume":"51","author":"Liu","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.apsb.2018.12.004","article-title":"Hypocrellin a-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway","volume":"9","author":"Qi","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0195","doi-asserted-by":"crossref","first-page":"085007","DOI":"10.1117\/1.JBO.19.8.085007","article-title":"Real-time analysis of endogenous protoporphyrin \u2168 fluorescence from \u03b4-aminolevulinic acid and its derivatives reveals distinct time- and dose-dependent characteristics in vitro","volume":"19","author":"Kiesslich","year":"2014","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.pdpdt.2020.101907_bib0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ijc.11223","article-title":"Iron chelation, angiogenesis and tumor therapy","volume":"106","author":"Linden","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pdpdt.2020.101907_bib0205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.20161","article-title":"Competing pathways of iron chelation: angiogenesis or anti-tumor activity: targeting different molecules to induce specific effects","volume":"110","author":"Le","year":"2004","journal-title":"Int. J. Cancer"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100020302611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100020302611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:34:32Z","timestamp":1761611672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100020302611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S1572100020302611"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101907","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101907"}}